albuterol has been researched along with Paralysis, Hyperkalemic Periodic in 2 studies
Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).
Paralysis, Hyperkalemic Periodic: An autosomal dominant familial disorder which presents in infancy or childhood and is characterized by episodes of weakness associated with hyperkalemia. During attacks, muscles of the lower extremities are initially affected, followed by the lower trunk and arms. Episodes last from 15-60 minutes and typically occur after a period of rest following exercise. A defect in skeletal muscle sodium channels has been identified as the cause of this condition. Normokalemic periodic paralysis is a closely related disorder marked by a lack of alterations in potassium levels during attacks of weakness. (Adams et al., Principles of Neurology, 6th ed, p1481)
| Excerpt | Relevance | Reference |
|---|---|---|
| "In patients with hyperkalemic periodic paralysis (HyperKPP), attacks of muscle weakness or paralysis are triggered by K(+) ingestion or rest after exercise." | 1.37 | Na+,K+-pump stimulation improves contractility in isolated muscles of mice with hyperkalemic periodic paralysis. ( Clausen, JD; Clausen, T; Hayward, LJ; Nielsen, OB; Pedersen, TH, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Stunnenberg, BC | 1 |
| Merkus, EC | 1 |
| Raaphorst, J | 1 |
| Saris, CG | 1 |
| Groenewoud, H | 1 |
| Statland, J | 1 |
| Weijma, R | 1 |
| van Vlijmen, B | 1 |
| Griggs, R | 1 |
| van Engelen, BGM | 1 |
| van der Wilt, GJ | 1 |
| Clausen, T | 1 |
| Nielsen, OB | 1 |
| Clausen, JD | 1 |
| Pedersen, TH | 1 |
| Hayward, LJ | 1 |
2 other studies available for albuterol and Paralysis, Hyperkalemic Periodic
| Article | Year |
|---|---|
N-of-1 trial of salbutamol in hyperkalaemic periodic paralysis.
Topics: Adrenergic beta-2 Receptor Agonists; Albuterol; Female; Humans; Paralysis, Hyperkalemic Periodic; Si | 2021 |
Na+,K+-pump stimulation improves contractility in isolated muscles of mice with hyperkalemic periodic paralysis.
Topics: Albuterol; Animals; Capsaicin; Electric Stimulation; Mice; Monensin; Muscle Contraction; Muscle, Ske | 2011 |